World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
135
Citations
70059
World Ranking
233
National Ranking
31

Medicine

D-Index
136
Citations
71046
World Ranking
1973
National Ranking
205

Overview

Roger A. Barker is affiliated with the University of Cambridge in the United Kingdom. Their research spans multiple disciplines within biomedical sciences, focusing notably on medicine, biochemistry, genetics, molecular biology, and neuroscience.

The scientist's publication record demonstrates significant engagement in neurology and molecular biology, with a considerable number of works contributing to cellular and molecular neuroscience, cognitive neuroscience, and physiology.

Research topics covered by Barker include Parkinson's disease mechanisms and treatments, neurological disorders and treatments, genetic neurodegenerative diseases, pluripotent stem cells, single-cell and spatial transcriptomics, mitochondrial function and pathology, as well as autism spectrum disorder research.

Frequent collaborators include Caroline H. Williams-Gray, Xiaoling He, Omer Ali Bayraktar, Sarah A. Teichmann, and Thomas Foltynie.

Typical venues for their research publications are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Movement Disorders
  • Journal of Parkinson s Disease
  • Journal of Neurology
  • Nature

Notable recent papers include:

  • A cell atlas of human thymic development defines T cell repertoire formation, 2020, Science
  • Cells of the human intestinal tract mapped across space and time, 2021, Nature
  • ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update, 2021, Stem Cell Reports
  • Comprehensive cell atlas of the first-trimester developing human brain, 2023, Science
  • Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines, 2020, UNC Libraries

Barker's scholarly contributions include extensive work on Parkinson's disease mechanisms and treatments, reflecting a specialized commitment to understanding this condition alongside broader interests in neurological disorders.

Their multidisciplinary approach integrates cellular and molecular methods with clinical neuroscience, supporting developments in genetic neurodegenerative disease research as well as stem cell biology and transcriptomics.

This breadth of focus aligns with publication trends evident in highly regarded scientific journals, which serve as platforms for disseminating research findings across medical and molecular biology communities.

Best Publications

  • RNA velocity of single cells

    Gioele La Manno;Gioele La Manno;Ruslan Soldatov;Amit Zeisel;Amit Zeisel;Emelie Braun;Emelie Braun

  • Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines

    Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand

  • A Functional Role for Adult Hippocampal Neurogenesis in Spatial Pattern Separation

    C. D. Clelland;M. Choi;C. Romberg;G. D. Clemenson

  • Evolution of cognitive dysfunction in an incident Parkinson's disease cohort

    C. H. Williams-Gray;T. Foltynie;C. E. G. Brayne;T. W. Robbins

  • The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

    Caroline H. Williams-Gray;Jonathan R. Evans;An Goris;An Goris;Thomas Foltynie

  • Enhanced or Impaired Cognitive Function in Parkinson's Disease as a Function of Dopaminergic Medication and Task Demands

    Roshan Cools;Roger A. Barker;Barbara J. Sahakian;Trevor W. Robbins

  • Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

    Angie A Kehagia;Roger A Barker;Trevor W Robbins

  • Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

    D. Aarsland;K. Bronnick;C. Williams-Gray;D. Weintraub

  • The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

    Thomas Foltynie;Carol E. G. Brayne;Trevor W. Robbins;Roger A. Barker

  • Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells

    Gioele La Manno;Gioele La Manno;Daniel Gyllborg;Simone Codeluppi;Simone Codeluppi;Kaneyasu Nishimura

  • A cell atlas of human thymic development defines T cell repertoire formation.

    Jong-Eun Park;Rachel A. Botting;Cecilia Domínguez Conde;Dorin-Mirel Popescu

  • The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

    Caroline H Williams-Gray;Sarah L Mason;Jonathan R Evans;Thomas Foltynie

  • Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach

    S J G Lewis;T Foltynie;A D Blackwell;T W Robbins

  • Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry.

    Simon J. G. Lewis;Anja Dove;Trevor W. Robbins;Roger A. Barker

  • Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis.

    Angie A. Kehagia;Roger A. Barker;Trevor W. Robbins

  • Cells of the human intestinal tract mapped across space and time.

    Rasa Elmentaite;Natsuhiko Kumasaka;Kenny Roberts;Aaron Fleming

  • l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease

    Roshan Cools;Roger A Barker;Barbara J Sahakian;Trevor W Robbins

  • The spectrum of nonmotor symptoms in early Parkinson disease

    Tien Kheng Khoo;Alison J Yarnall;Gordon W Duncan;Shirley Coleman

  • Microglial activation correlates with severity in Huntington disease A clinical and PET study

    N. Pavese;A. Gerhard;Y. F. Tai;A. K. Ho

  • Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

    Stéphane Palfi;Jean Marc Gurruchaga;G Scott Ralph;Helene Lepetit

  • Mechanisms of cognitive set flexibility in Parkinson's disease.

    Roshan Cools;Roger A. Barker;Barbara J. Sahakian;Trevor W. Robbins

  • Dopaminergic modulation of high‐level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET

    Roshan Cools;Elka Stefanova;Roger A. Barker;Trevor W. Robbins

Frequent Co-Authors

Thomas Foltynie
Thomas Foltynie University College London
David J. Burn
David J. Burn Newcastle University
James B. Rowe
James B. Rowe University of Cambridge
Trevor W. Robbins
Trevor W. Robbins University of Cambridge
Stephen B. Dunnett
Stephen B. Dunnett Cardiff University
Anne Elizabeth Rosser
Anne Elizabeth Rosser Cardiff University
Adrian M. Owen
Adrian M. Owen University of Western Ontario
David J. Brooks
David J. Brooks Newcastle University
Nicholas W. Wood
Nicholas W. Wood University College London
Paola Piccini
Paola Piccini Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Roger A. Barker

Trending Scientists

Recently Published Articles